Boehringer Ingelheim open new plant in Catalonia

pharmafile | June 17, 2019 | News story | Sales and Marketing Boehringer Ingelheim, Catalonia, Sant Cugat de Valles, barcelona, pharma 

Boehringer Ingelheim has opened a new manufacturing facility in the town of Sant Cugat del Vallès near Barcelona.

The new plant will manufacture Boehringer Ingelheim’s COPD and asthma drug Respimat.

The Catalonia facility has seen Boheringer invest €120 million into the new plant which will see the creation of up to 200 new jobs.

Advertisement

Peter Ploeger, Managing Director of Boehringer Ingelheim Spain, commented: “This new plant is a recognition of the excellence and professionalism of hundreds of workers who, through their dedication, efforts, and commitment, have positioned the Boehringer Ingelheim facilities in Sant Cugat as one of the Group’s European innovation hubs, and a global leader due to its excellence, quality and environmental standards.”

The 17,000 sqm facility will include production areas, laboratories, technical areas, warehouses and an office.

Louis Goss

Related Content

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis

Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a …

blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed …

The Gateway to Local Adoption Series

Latest content